1. THE PUBLIC CONSULTATION
responses were received ( via the on-line survey, and by )
A Report was published on 24th July*. *

2. THE PUBLIC CONSULTATION: SOME FINDINGS
In general, respondents expressed diverging views on how to define criteria and how endocrine disruptors should be regulated.
Overall, responses suggested that there is a need for the EU to establish definitive criteria for endocrine disruptors.
The option of no policy change (the interim criteria set in the PPPR and BPR continue to apply) is not supported.
Authorities from non-EU MS stressed the potential impact on trade.

3. THE IMPACT ASSESSMENT TIMELINE
Spring
2015
Delivery methodology screening (JRC)
Start screening substances (contractor)
Summer
Stakeholders conference (June 1st)
Publication of stakeholders' report (24th of July)
Autumn
Results of screening substances
Technical meeting on screening methodology
2016
IA Report